drugset / Trial / NCT00487240

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

NCT00487240

Phase 3 Completed 387 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the efficacy and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.

Timeline

Start
2007-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic Subcutaneous
Comparator insulin detemir Protein / enzyme biologic Subcutaneous